Project Grant HT94252310297
Award Date
5/1/23
Completion Date
4/30/26
Dollars Obligated
$539K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Detroit, MI 48202, USA
Similar Awards
The Defense Health Agency awarded Wayne State University a $616,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to investigate the molecular mechanisms and therapeutic potential of the RNA methyltransferase FTSJ3 in regulating ribosome biogenesis in liver cancer. The project will be conducted over a 2-year period from September 30, 2023 to September 29, 2025. As a premier public research university, Wayne State University has a track record of...
The Department of the Army Medical Command awarded Wayne State University $533,261 under the Military Medical Research and Development federal grant program (CFDA 12.420) for the period of July 1, 2022 through June 30, 2025. The award will support the university's project "MNRR1, A Novel Mechanistic Target for Triple-Negative Breast Cancer Metastasis." Through this funding, Wayne State University researchers will investigate medical solutions for triple-negative breast cancer...
The U.S. Department of Defense's Defense Health Agency awarded a $693,000 Project Grant to Wayne State University in Detroit, Michigan under the Military Medical Research and Development program (CFDA 12.420). The grant supports the university's "EPIGENETIC THERAPEUTIC TARGETING OF ENHANCER HUBS FOR BREAST CANCER" research project, which aims to develop new treatments for breast cancer. The 3-year award, running from December 15, 2023 to December 14, 2026, will fund basic,...
This $924,000 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at Wayne State University to target dual-specificity phosphatase 1 in platinum resistance in ovarian cancer. The award, which runs from July 1, 2024 to June 30, 2028, will enable Wayne State to conduct innovative scientific studies to improve treatment options and outcomes for this challenging form of cancer, which disproportionately impacts...
Wayne State University was awarded a $1,386,000 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420). The grant will fund a novel strategy targeting the metabolic vulnerability of castration-resistant prostate cancer (CRPC) from July 1, 2023 to June 30, 2026. Through this award, Wayne State University researchers will investigate medical solutions for prostate cancer by developing and applying an innovative approach focused on CRPC's...
This $385,000 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports Wayne State University's research to develop therapeutic approaches targeting spiral ganglion-cochlear nucleus synaptopathy. The two-year award, running from September 1, 2023 to August 31, 2025, aims to transform health care for Service Members and the American public through innovative and impactful biomedical research. As a prominent public...
The Department of the Army Medical Command awarded Wayne State University a $621,739 project grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research on MNRR1, a novel mechanistic target for triple-negative breast cancer metastasis from July 1, 2022 to June 30, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care...
The Washington State University will receive $1,377,000 from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research on the novel role and therapeutic targeting of LMO4 in lethal prostate cancer from July 1, 2023 to June 30, 2026. Through this three-year Project Grant, WSU researchers will investigate medical solutions for the battlefield by exploring the oncogenic functions of LMO4 and developing targeted therapies to...
The U.S. Department of Defense's Defense Health Agency awarded a $643,558 Project Grant to Wright State University on August 12, 2024 under the Military Medical Research and Development program (CFDA 12.420). This grant supports research on "IMMUNOTOXICANT EXPOSURES AND INDIVIDUALIZED IMMUNE MODULATION VIA VARIANTS" over a 3-year performance period ending on August 11, 2027. As a leading research university, Wright State University has extensive experience conducting biomedical...
The Defense Health Agency awarded a $607,377 Project Grant to the Regents of the University of Michigan to fund a 2-year research project titled "A NEW IDEA FOR ADVANCING AXITINIB-BASED THERAPY IN RECURRENT AND METASTATIC HNSCC." This grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform healthcare for service members and the public. The University of Michigan, a leading...